Burke Pharmaceutical Research   Report issue

For profit Phase 3 Phase 4
Founded: Bryant AR United States (2009)

Organization Overview

First Clinical Trial
2010
NCT01174030
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

spinosad (natroba) (1 trial)

Drugs in Phase 3 Trials (3)

betamethasone (celestone) (1 trial)

brimonidine (alphagan) (2 trials)

calcipotriene (dovonex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erythema (Phase 3)

Lice Infestations (Phase 4)

Psoriasis (Phase 3)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4